Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab

• Glavni autori: Muñoz-Villegas P (Autor), Sanchez-Rios A (Autor), Quinonez-Alvarado MG (Autor), Olvera-Montaño O (Autor), Quintana-Hau JD (Autor), Baiza-Duran L (Autor)
• Format: Knjiga
• Izdano: Dove Medical Press, 2021-05-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Patricia Muñoz-Villegas,1 Alejandra Sanchez-Rios,1 Mayra G Quinonez-Alvarado,2 Oscar Olvera-Montaño,1 Juan D Quintana-Hau,2 Leopoldo Baiza-Duran1 1Medical Affairs Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, México; 2Research and Development Department (CIS), Zapopan, Jalisco, Mé...